Partnerships

Wacker Biotech partners with RNAV8 Bio to advance mRNA-based therapies, enhancing the biopharmaceutical landscape. The collaboration leverages Wacker's expertise in pDNA, mRNA production, and LNP formulation with RNAV8's mRNA engineering,…

Biotechnology innovation drives new therapies, with small and mid-size pharma firms playing a key role despite the challenges posed by larger companies and complex regulations. The global biotechnology market is…